BridgeBio Pharma, Inc 10-K for FY2024
BridgeBio Pharma, Inc. (BBIO)
10-K
2025-02-20
For: 2024-12-31
View Original
Added on
April 08, 2026
About this 10-K
BridgeBio Pharma, Inc filed this 10-K on February 20, 2025, covering the fiscal year ended December 31, 2024 (FY2024).
Headline figures
Fiscal year ended December 31, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $221.9M
- up 2285.3% from $9.3M a year earlier
- Net loss
- $543.35M
- compared with a net loss of $653.25M a year earlier
- Diluted EPS
- -$2.88
- compared with -$3.95 a year earlier